Contract Deobligations Alert — March 29, 2026

Combined $699M obligations with $494M outlays through 2029 signal reliable revenue for health tech leaders via full competition wins.

$288M fully obligated through 2027-2028 with $44M outlays indicate predictable cash flows in security and investment management.

$347M DOI obligation fully spent, yet $3.3B options unexercised in short 2-year facilities contract tempers growth potential.

Firm fixed price on 60% of value ($800M+) risks margin compression if costs overrun amid partial outlays (e.g., Idemia $0 outlayed).

Extended terms to 2029 expose $1.3B to federal budget shifts or terminations, with nonprofits facing scalability limits.

$5.8B unexercised options (4x obligated value) across records, led by Family Endeavors ($3.3B) and Carahsoft ($1.6B).

HHS dominance ($699M, 52%) in software/R&D signals multi-year health tech expansion via NAICS 511210/541715.

52% of deobligations ($699M) tied to CMS/NIH software and R&D with $494M outlays, favoring established non-small businesses.

80% of value in contracts to 2027+ underscores predictable funding despite deobligation stream.

{"entity"=>"Family Endeavors", "reason"=>"$3.3B options dwarf $347M obligation; nonprofit status caps returns vs. for-profit peers.", "trigger"=>"option exercise announcements or extensions to 2025-11"}

{"entity"=>"Idemia National Security", "reason"=>"$204M obligation with $0 outlay signals execution delays in 10-year passport contract.", "trigger"=>"outlay acceleration or State Dept modifications"}

{"title"=>"$465M HHS software with $1.6B upside to 2028.", "entity"=>"Carahsoft Technology", "reason"=>"Largest obligation at 35% of total; $128M remaining outlays.", "trigger"=>"CMS option exercises"}